Your browser doesn't support javascript.
loading
PCYT1A suppresses proliferation and migration via inhibiting mTORC1 pathway in lung adenocarcinoma.
Yu, Jing; Wu, Changtao; Wu, Qi; Huang, Jiafeng; Fu, Wenjuan; Xie, Xuemei; Li, Wen; Tang, Weizhong; Xu, Chuan; Jin, Guoxiang.
Afiliação
  • Yu J; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Educat
  • Wu C; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China; Department of Colorectal and Anal Surgery, The First Affiliated Hospital
  • Wu Q; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Huang J; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Fu W; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China.
  • Xie X; Department of Pathology, The Affiliated Hospital of North Sichuan Medical College, Nanchong, 637100, China.
  • Li W; Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu, 610047, China.
  • Tang W; Department of Gastrointestinal Surgery, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, 530021, China.
  • Xu C; Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, 646000, China; Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology
  • Jin G; Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University (Army Medical University), And Key Laboratory of Tumor Immunopathology, Ministry of Education of China, Chongqing, China. Electronic address: gxjinking@hotmail.com.
Biochem Biophys Res Commun ; 529(2): 353-361, 2020 08 20.
Article em En | MEDLINE | ID: mdl-32703435
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Colina-Fosfato Citidililtransferase / Alvo Mecanístico do Complexo 1 de Rapamicina / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Colina-Fosfato Citidililtransferase / Alvo Mecanístico do Complexo 1 de Rapamicina / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: Biochem Biophys Res Commun Ano de publicação: 2020 Tipo de documento: Article